ID A6VLQ9_ACTSZ Unreviewed; 1029 AA.
AC A6VLQ9;
DT 21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT 21-AUG-2007, sequence version 1.
DT 27-MAR-2024, entry version 72.
DE SubName: Full=Acriflavin resistance protein {ECO:0000313|EMBL:ABR73906.1};
GN OrderedLocusNames=Asuc_0531 {ECO:0000313|EMBL:ABR73906.1};
OS Actinobacillus succinogenes (strain ATCC 55618 / DSM 22257 / CCUG 43843 /
OS 130Z).
OC Bacteria; Pseudomonadota; Gammaproteobacteria; Pasteurellales;
OC Pasteurellaceae; Actinobacillus.
OX NCBI_TaxID=339671 {ECO:0000313|EMBL:ABR73906.1, ECO:0000313|Proteomes:UP000001114};
RN [1] {ECO:0000313|Proteomes:UP000001114}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 55618 / DSM 22257 / CCUG 43843 / 130Z
RC {ECO:0000313|Proteomes:UP000001114};
RX PubMed=21118570; DOI=10.1186/1471-2164-11-680;
RA McKinlay J.B., Laivenieks M., Schindler B.D., McKinlay A.A.,
RA Siddaramappa S., Challacombe J.F., Lowry S.R., Clum A., Lapidus A.L.,
RA Burkhart K.B., Harkins V., Vieille C.;
RT "A genomic perspective on the potential of Actinobacillus succinogenes for
RT industrial succinate production.";
RL BMC Genomics 11:680-680(2010).
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000746; ABR73906.1; -; Genomic_DNA.
DR AlphaFoldDB; A6VLQ9; -.
DR STRING; 339671.Asuc_0531; -.
DR KEGG; asu:Asuc_0531; -.
DR eggNOG; COG0841; Bacteria.
DR HOGENOM; CLU_002755_1_2_6; -.
DR OrthoDB; 9758297at2; -.
DR Proteomes; UP000001114; Chromosome.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR GO; GO:0022857; F:transmembrane transporter activity; IEA:InterPro.
DR Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR InterPro; IPR027463; AcrB_DN_DC_subdom.
DR InterPro; IPR001036; Acrflvin-R.
DR PANTHER; PTHR32063; -; 1.
DR PANTHER; PTHR32063:SF28; BLR2861 PROTEIN; 1.
DR Pfam; PF00873; ACR_tran; 1.
DR PRINTS; PR00702; ACRIFLAVINRP.
DR SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE 4: Predicted;
KW Membrane {ECO:0000256|SAM:Phobius};
KW Reference proteome {ECO:0000313|Proteomes:UP000001114};
KW Transmembrane {ECO:0000256|ARBA:ARBA00022692, ECO:0000256|SAM:Phobius};
KW Transmembrane helix {ECO:0000256|ARBA:ARBA00022989,
KW ECO:0000256|SAM:Phobius}.
FT TRANSMEM 332..351
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 358..378
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 384..408
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 429..449
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 461..479
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 523..542
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 843..863
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 870..894
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 947..968
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 980..1006
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
SQ SEQUENCE 1029 AA; 111388 MW; 9EF9964131681441 CRC64;
MKFTDIFIKR PVMAICISLL IVILGLQAIS KLSVREYPKM TTTVITVSTT YAGADAGLIQ
AFVTSKLEEA IAQADNIDYL SSSSAPSSST ITVKMKLNTD PASALADVLS KVQSVRSELP
SGIEDPTLTS STGGSGIMYI SFRSDKLHPS QVTDYIERVV KPQLFTVEGV AKVNVYGAAE
YAMRIWLDPQ KLAAQNLSAS QIATALANNN VQTAAGNDKG YFNVYRNKVE TTTNTVEDLG
NLIVYSDGEK LVRLRDVADV ELNKESDNTR AAANGSDAVV LGIEPTSNAN PLDVADKIRP
LYDTIKKNLP NSIESDILYD RTVAINSSIN DVIHTIVEAV VIVLVVIMMF IGSLRAILIP
IITIPISLIG VVFLLQALDF SLNLMTLLAM ILAIGLVVDD AIVVLENVDR HIKEGETPFR
AAIIGTREIA VPVISMTIAL VAVYSPMALM GGITGTLFKE FALTLAGAVF ISGIIALTLS
PMMSGKMLKH ESSKFEEKVN RTLTKITNIY TYILGLVMQT RKAILLFAVI IFATLPVLFT
ALSSELTPTE DKGGFLGMVT APSNVNVDYV QQATKPYEEI LDNTPEKQYS QVIAGAPNTN
QALVITTLKD WSERSRTQAE VMAELTAKAA EIPEVSISAF AFPEIETGEQ GPPVVIVLSS
PGSTKELAQV AETFLDKIRK SGKFVYSNLT LKYDVAQMRI KVDKEKAGTY GITMQQIAST
LGYYLSEATI TRVDIDGRAY KVISQVKREN RLSPESLKNY YISASNGESV PLSSLLDVTL
EPQPYSLPRF SQLNAAEIQM VPSPTTTTGD AIAWLQEAAK DLPQGYSYDW KGEARQLVQE
GNALATTFIL AVLIIFLVLA IQFESIRDPM VILVSVPLAI SGALLVLNLL SFFGVTGVTL
NIYSEVGLIT LVGLITKHGI LMCEVAKEEQ LNHGKNKMEA IMTAAQLRLR PILMTTAAMI
AGLVPLLYAS GAGAVMRFSM GVVVVAGLAI GTLFTLFVLP VIYTYLGSDH EPLPEFDENA
PRISQGESH
//
